Access

Research Highlights

Nature Reviews Cancer 8, 411 (1 June 2008) | doi:10.1038/nrc2414

In Brief

Metabolism The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth Firestein, R. et al. PLoS ONE 3, e2020 (2008) Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator Lain, S. et al. Cancer Cell 13, 454–463 (2008) Conflicting data have led to the question of whether sirtuin 1 (SIRT1), thought to be a key mediator of the tumour-suppressive effects of calorie restriction, is an oncogene or a tumour suppressor in vivo. Using the Apcmin/+ mouse model of colon cancer, Firestein and colleagues found that SIRT1 deacetylates β-catenin, preventing its oncogenic activity.